Na⁺/Ca²⁺ exchanger 1 inhibition abolishes ischemic tolerance induced by ischemic preconditioning in different cardiac models

详细信息    查看全文

• 作者：Pasqualina Castaldo^a ; ¹ ; ^{p.castaldo@univpm.it} ; Maria Loredana Macrì ; ^a ; ¹ ; ^{m.l.macri@univpm.it} ; Vincenzo Lariccia^a ; ^{v.lariccia@univpm.it} ; Alessandra Matteucci^a ; ^{a.matteucci@univpm.it} ; Marta Maiolino^a ; ^{maiolinomarta.mm@gmail.com} ; Santo Gratteri^b ; ^{gratteri@unicz.it} ; Salvatore Amoroso^a ; ^{s.amoroso@univpm.it} ; Simona Magi^a ; ^{s.magi@univpm.it}
• 关键词：[Ca2+]i ; Intracellular Ca2+ concentration ; HPC ; Hypoxic Preconditioning ; H/R ; Hypoxia/Reoxygenation ; IPC ; Ischemic Preconditioning ; I/R ; Ischemia/Reperfusion ; LDH ; Lactate Dehydrogenase ; NCX ; Na+/Ca2+exchanger ; SN-6 ; 2-[[4-[(4Nitrophenyl) methoxy] phenyl] methyl]&minus ; 4-thiazolidinecarboxylic acid ethyl ester ; TTC ; Triphenyltetrazolium chloride ; WT ; Wild Type
• 刊名：European Journal of Pharmacology
• 出版年：2017
• 出版时间：5 January 2017
• 年：2017
• 卷：794
• 期：Complete
• 页码：246-256
• 全文大小：1531 K
• 卷排序：794

文摘

Ca2+-handling disturbances play an important role in the genesis of myocardial ischemia/reperfusion (I/R) injury. Ischemic preconditioning (IPC) is a powerful strategy to induce tolerance against subsequent ischemic episodes. IPC signaling pathways may be triggered by Ca2+ ion. Since Na+/Ca2+ exchanger 1 (NCX1) participates in modulating intracellular Ca2+ homeostasis, here we further defined its role in I/R and investigated its potential involvement in IPC-induced cardioprotection. In isolated ventricular cardiomyocytes, perfused rat heart and H9c2 cardiomyoblasts, I/R produced a significant cell injury, assessed by measuring extracellular lactate dehydrogenase (LDH) and, for the whole heart, also by estimating myocardial infarct size area. Characterization of cell death revealed the involvement of apoptotic processes. Interestingly, I/R challenge induced NCX1 protein upregulation. In NCX1-transfected H9c2 cells, exchanger protein upregulation was accompanied by an increase in its reverse mode activity. The effects of I/R on extracellular LDH and infarct size area were drastically reduced by 1 μM SN-6, a selective NCX1 inhibitor. Moreover, SN-6 also prevented I/R-induced increase of NCX1 reverse-mode activity and protein upregulation. These results suggested a deleterious role of NCX1 in I/R-induced cell damage.In both isolated cardiomyocytes and perfused heart, IPC followed by I/R afforded cardioprotection, reducing extracellular LDH release and limiting ischemic area extent. Interestingly, NCX1 blockade (1 μM SN-6) completely abolished IPC protection against I/R, leading to exacerbation of cell injury, massive infarct size area and restoration of NCX1 protein expression.These findings suggest that NCX1 is deleterious in I/R, whereas it may be beneficial in promoting IPC-induced cardioprotection.